3 results
Approved WMOCompleted
To compare the effect of semaglutide 1.0 mg once-weekly versus exenatide extended release (ER) 2.0 mg once-weekly on glycaemic control after 56 weeks of treatment.
Approved WMOCompleted
The purpose of the study is to investigate to what extent MMI-0100 is tolerated after multiple administrations.It will also be investigated how quickly and to what extent MMI-0100 is absorbed and eliminated from the body (this is called…
Approved WMOCompleted
The purpose of this study is to investigate how safe, and how well tolerated, the new study drug NNC0480-0389 is when it is given together with semaglutide. It will also be investigated how quickly and to what extent NNC0480-0389 and semaglutide are…